[go: up one dir, main page]

CN104649901B - A kind of preparation method of the material medicine ingenol methyl butene acid esters for treating actinic keratosiss - Google Patents

A kind of preparation method of the material medicine ingenol methyl butene acid esters for treating actinic keratosiss Download PDF

Info

Publication number
CN104649901B
CN104649901B CN201510066743.3A CN201510066743A CN104649901B CN 104649901 B CN104649901 B CN 104649901B CN 201510066743 A CN201510066743 A CN 201510066743A CN 104649901 B CN104649901 B CN 104649901B
Authority
CN
China
Prior art keywords
silica gel
methanol
petroleum ether
ingenol
obtains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510066743.3A
Other languages
Chinese (zh)
Other versions
CN104649901A (en
Inventor
邱明华
万落生
彭惺蓉
李忠荣
周琳
于慕湲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kunming Institute of Botany of CAS
Original Assignee
Kunming Institute of Botany of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kunming Institute of Botany of CAS filed Critical Kunming Institute of Botany of CAS
Priority to CN201510066743.3A priority Critical patent/CN104649901B/en
Publication of CN104649901A publication Critical patent/CN104649901A/en
Application granted granted Critical
Publication of CN104649901B publication Critical patent/CN104649901B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • C07C67/56Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/48Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533Monocarboxylic acid esters having only one carbon-to-carbon double bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/76Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/84Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing rings with more than eight members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

一种治疗光化性角化病的原料药物巨大戟醇甲基丁烯酸酯的制备方法,包括下述步骤:原料提取、石油醚萃取、大孔树脂D101吸附干法拌样划段、硅胶分离、Sephadex凝胶纯化、DIOL硅胶纯化。该方法从南欧大戟全草植物分离原料药物巨大戟醇甲基丁烯酸酯,具备分离纯化快捷简单,高效高纯,成本较低等优点。A method for preparing a raw material drug ingenol methacrylate for treating actinic keratosis, comprising the following steps: raw material extraction, petroleum ether extraction, macroporous resin D101 adsorption dry method mixing section, silica gel Separation, Sephadex gel purification, DIOL silica gel purification. The method separates the raw drug ingenol methacrylate from the whole plant of Euphorbia euphorbia, and has the advantages of fast and simple separation and purification, high efficiency and high purity, and low cost.

Description

一种治疗光化性角化病的原料药物巨大戟醇甲基丁烯酸酯的 制备方法A raw material drug ingenol methacrylate for treating actinic keratosis Preparation

技术领域:Technical field:

本发明属于药物制备方法技术领域,具体地,涉及一种治疗光化性角化病原料药物巨大戟醇的制备方法。The invention belongs to the technical field of medicine preparation methods, and in particular relates to a preparation method of ingenol, a raw material medicine for treating actinic keratosis.

背景技术Background technique

2012年1月23日美国FDA批准了巨大戟醇甲基丁烯酸酯(Ingenol Mebutate),作为用于治疗光化性角化病(Actinic Keratosis,AK,对阳光敏感的一种皮肤病)药物上市。该药物的商品名Picato,由LEO Pharma AS研发成功。On January 23, 2012, the US FDA approved Ingenol Mebutate as a drug for the treatment of Actinic Keratosis (AK, a skin disease sensitive to sunlight) listed. The drug, trade name Picato, was successfully developed by LEO Pharma AS.

巨大戟醇甲基丁烯酸酯(Ingenol Mebutate),可以从大戟属植物(Euphorbia)中提取分离纯化,如Euphorbia peplus,Euphorbia hirta,Euphorbia drummondi,及中药Euphorbia lathyris(千金子),Euphorbia kansui(甘遂)等同属植物都含有该原料药物。但该原料药物含量很低,而其Ingenol Mebutate的母核骨架化合物Ingenol,同属植物中也分布很广,可供提取分离纯化。母核Ingenol为四环二萜天然产物,其中B环、C环是由环张力非常大的bicyclic[4,4,1]undecane构成,由于其桥头上的inside-outsidestereochemistry,即构成C环的C-11到C-14在桥头异侧,使其张力大增。合成化学家对此特殊立体化学现象特别感兴趣,也使得Ingenol的全合成研究成为热点,Wood,Tanino/Kuwajima,Winkler,Funk,Rigby等研究团队都完成了Ingenol的全合成研究。最便捷的Ingenol全合成仅需七步反应。使得原料药物巨大戟醇甲基丁烯酸酯(Ingenol Mebutate)可以从合成和半合成途径得到。Ingenol Mebutate can be extracted, isolated and purified from Euphorbia plants, such as Euphorbia peplus, Euphorbia hirta, Euphorbia drummondi, and traditional Chinese medicine Euphorbia lathyris (daughter of gold), Euphorbia kansui ( Gansui) and other plants of the same genus all contain the raw material medicine. However, the content of the raw drug is very low, and its Ingenol Mebutate's mother core skeleton compound Ingenol is also widely distributed in the same genus of plants, which can be used for extraction, separation and purification. The mother core Ingenol is a tetracyclic diterpene natural product, in which the B ring and C ring are composed of bicyclic[4,4,1]undecane with very large ring tension, due to the inside-outsidestereochemistry on the bridgehead, that is, the C -11 to C-14 are on the opposite side of the bridgehead, greatly increasing its tension. Synthetic chemists are particularly interested in this special stereochemical phenomenon, which also makes the total synthesis of Ingenol a hot spot. Wood, Tanino/Kuwajima, Winkler, Funk, Rigby and other research teams have completed the total synthesis of Ingenol. The most convenient total synthesis of Ingenol requires only seven steps. The raw material drug Ingenol Mebutate can be obtained from synthetic and semi-synthetic routes.

南欧大戟(Euphorbia peplus Linn),原产地中海沿岸(南欧至北非),归化于亚洲、美洲和澳大利亚;我国的台湾(台北、台中)、广东、香港、福建(厦门、福州)、广西(南宁)和云南(昆明)相继发现归化植株或种群,作为大戟属植物的一种,南欧大戟在云南省已经广泛分布,田边地头,园林绿化区域,随处可见,因其乳汁具有毒性,不能作为牧草,资源极大,是巨大戟醇甲基丁烯酸酯的原料资源基础。Southern European euphorbia (Euphorbia peplus Linn), native to the Mediterranean coast (Southern Europe to North Africa), naturalized in Asia, America and Australia; my country's Taiwan (Taipei, Taichung), Guangdong, Hong Kong, Fujian (Xiamen, Fuzhou), Guangxi ( Nanning) and Yunnan (Kunming) successively found naturalized plants or populations. As a kind of Euphorbia plant, Southern European Euphorbia has been widely distributed in Yunnan Province. It can be seen everywhere in fields and landscaping areas, because its milk is toxic. , can not be used as pasture, the resources are huge, and it is the raw material resource base of ingenol methacrylate.

迄今为止,现有技术中未见有从南欧大戟中提取巨大戟醇甲基丁烯酸酯工业药物原料的工艺方法的报道。So far, there is no report on the process of extracting ingenol methacrylate industrial pharmaceutical raw material from Euphorbia euphorbia in the prior art.

发明内容Contents of the invention

本发明的目的在于提供一种从广布云南地区的外来植物南欧大戟(Euphorbiapeplus) 中提取分离纯化天然原料药物巨大戟醇甲基丁烯酸酯(Ingenol Mebutate)的方法。该工艺方法具备分离纯化快捷简单,高效高纯,成本较低等优点。The object of the present invention is to provide a method for extracting, separating and purifying natural raw material drug Ingenol Mebutate from the exotic plant Euphorbiapeplus widely distributed in Yunnan area. The process method has the advantages of fast and simple separation and purification, high efficiency and high purity, and low cost.

为了实现本发明的上述目的,本发明提供了如下的技术方案:In order to realize the above-mentioned purpose of the present invention, the present invention provides following technical scheme:

巨大戟醇甲基丁烯酸酯的制备方法,包括下述步骤:原料提取、石油醚萃取、大孔树脂D101吸附干法拌样划段、硅胶分离、Sephadex凝胶纯化、DIOL硅胶纯化;The preparation method of ingenol methyl crotonate comprises the following steps: raw material extraction, petroleum ether extraction, macroporous resin D101 adsorption dry method sample mixing section, silica gel separation, Sephadex gel purification, DIOL silica gel purification;

所述的原料提取为:采集各地的南欧大戟或同属植物全草,在自然阳光下晾晒干燥,切碎后以甲醇浸泡,加热回流提取三次,过滤除去残渣,滤液浓缩后得总浸膏;The extraction of the raw materials is as follows: collect Euphorbia euphorbia or the whole plant of the same genus from various places, dry it in the sun under natural sunlight, soak it in methanol after chopping, heat and reflux for extraction three times, filter to remove the residue, and obtain the total extract after concentrating the filtrate;

所述的石油醚萃取为:总浸膏水混悬分散后,以体积比1:1石油醚萃取3次,分液浓缩石油醚部分,得石油醚总浸膏;The petroleum ether extraction is as follows: after the total extract is suspended and dispersed in water, it is extracted 3 times with petroleum ether at a volume ratio of 1:1, and the petroleum ether part is separated and concentrated to obtain the total extract of petroleum ether;

所述的大孔树脂D101吸附干法拌样划段是用石油醚总浸膏,用适量氯仿溶解,与大孔树脂D101干法拌样,然后用大孔树脂柱粗分离,以甲醇/水溶液作为流动相,按40%、60%、80%、100%洗脱,收集80%甲醇水溶液洗脱洗脱流份,减压浓缩回收溶液,得到浸膏为总二萜部位;The section of the macroporous resin D101 adsorption dry sample mixing is to use the total extract of petroleum ether, dissolve it with an appropriate amount of chloroform, mix the sample with the macroporous resin D101 dry method, and then roughly separate it with a macroporous resin column, and use methanol/water solution As the mobile phase, elute at 40%, 60%, 80%, and 100%, collect 80% methanol aqueous solution to elute the eluted fraction, concentrate and recover the solution under reduced pressure, and obtain the extract as the total diterpene fraction;

所述硅胶分离为:以适量氯仿溶解后硅胶拌样,装硅胶柱粗分离,用石油醚/乙酸乙酯作为洗脱液进行梯度洗脱,得到8个主要部位Fr I-VIII,其中Fr VII以C18柱分离,再得10个亚部位subFr1-10;The silica gel separation is as follows: the silica gel sample is mixed with an appropriate amount of chloroform, the silica gel column is installed for rough separation, and petroleum ether/ethyl acetate is used as the eluent for gradient elution to obtain 8 main parts Fr I-VIII, wherein Fr VII Separation with C18 column to obtain 10 sub-parts subFr1-10;

所述Sephadex凝胶纯化为:对亚部位subFr8-9,再上Sephadex凝胶柱用甲醇洗脱,收集流份浓缩,得到目标化合物单体;The Sephadex gel purification is as follows: for the sub-site subFr8-9, and then eluted with methanol on the Sephadex gel column, the collected fractions are concentrated, and the target compound monomer is obtained;

所述DIOL硅胶纯化为:得到单体化合物,经DIOL硅胶再次分离纯化,得到纯度98%以上巨大戟醇甲基丁烯酸酯。The DIOL silica gel purification is as follows: the monomer compound is obtained, which is separated and purified again by DIOL silica gel to obtain ingenol methacrylate with a purity of more than 98%.

如所述的巨大戟醇甲基丁烯酸酯的制备方法,其中所述的方法关键步骤为大孔树脂D101吸附拌样划段得到总二萜部位;Sephadex凝胶柱层析纯化得到化合物单体;DIOL硅胶柱层析纯化得到高纯目标原料单体。As described in the preparation method of ingenol methyl crotonate, wherein the key step of the method is to obtain the total diterpene parts by adsorption and mixing of macroporous resin D101; Sephadex gel column chromatography purification to obtain the compound single body; purified by DIOL silica gel column chromatography to obtain high-purity target raw material monomer.

如所述的巨大戟醇甲基丁烯酸酯的制备方法,其中所述的方法为取南欧大戟全草,干燥,切碎后以甲醇浸泡,加热回流提取三次,过滤除去残渣,滤液浓缩后得总浸膏,浸膏以20L水混悬分散后,体积比1:1石油醚萃取5次,浓缩石油醚部分,得石油醚总浸膏,以适量氯仿溶解浸膏,用大孔树脂D101干法拌样,然后用大孔树脂柱粗分离,以甲醇/水溶液作为流动相,按40%、60%、80%、100%洗脱;对80%甲醇洗脱液浓缩回收得总二萜部位,以适量氯仿溶解后硅胶200~300目拌样,装硅胶柱粗分离,以20:1-0:1 的石油醚:乙酸乙酯进行梯度洗脱,得到8个主要部位Fr I-VIII,其中Fr VII以C18柱分离,得10个亚部位subFr1-10,subFr9再上sephadex凝胶柱用甲醇洗脱,得到纯度90%以上的目标化合物,再次经DIOL分离纯化,得到纯度98%以上的巨大戟醇甲基丁烯酸酯Ingenol Mebutate。The preparation method of ingenol methyl crotonate as described above, wherein the method is to take the whole plant of Euphorbia euphorbia, dry it, chop it, soak it in methanol, extract it under reflux for three times, filter to remove the residue, and concentrate the filtrate Finally, the total extract was obtained. After the extract was suspended and dispersed in 20L of water, it was extracted 5 times with petroleum ether at a volume ratio of 1:1, and the petroleum ether part was concentrated to obtain the total extract of petroleum ether. D101 dry mixed sample, then roughly separated with a macroporous resin column, using methanol/water solution as mobile phase, and eluted at 40%, 60%, 80%, 100%; 80% methanol eluate was concentrated and recovered to obtain total two For the terpene part, after dissolving with an appropriate amount of chloroform, mix the sample with 200-300 mesh silica gel, install a silica gel column for rough separation, and perform gradient elution with 20:1-0:1 petroleum ether: ethyl acetate to obtain 8 main parts Fr I- VIII, wherein Fr VII was separated by C18 column to obtain 10 sub-parts subFr1-10, and subFr9 was eluted with methanol on a sephadex gel column to obtain the target compound with a purity of more than 90%, which was separated and purified by DIOL again to obtain a purity of 98%. Ingenol Mebutate above.

具体实施方式detailed description

下面用本发明的实施例来进一步说明本发明的实质性内容,但并不以此来限定本发明。The following examples of the present invention are used to further illustrate the substantive content of the present invention, but the present invention is not limited thereto.

实施例1Example 1

Ingenol Mebutate的制备:Preparation of Ingenol Mebutate:

1.原料甲醇提取:采集各地的南欧大戟(Euphorbia peplus Linn)或同属植物全草,在自然阳光下晾晒干燥,切碎后以甲醇浸泡,加热回流提取三次,过滤除去残渣,滤液浓缩后得总浸膏。1. Methanol extraction of raw materials: Collect Euphorbia peplus Linn or the whole plant of the same genus from various places, dry it in the sun, chop it, soak it in methanol, extract it under reflux for three times, filter to remove the residue, and concentrate the filtrate to obtain total extract.

2.石油醚萃取:总浸膏水混悬分散后,以体积比1:1石油醚萃取3次,分液浓缩石油醚部分,得石油醚总浸膏。2. Petroleum ether extraction: After the total extract was suspended and dispersed in water, it was extracted 3 times with petroleum ether at a volume ratio of 1:1, and the petroleum ether part was concentrated by liquid separation to obtain the total extract of petroleum ether.

3.大孔树脂D101吸附干法拌样划段:石油醚总浸膏用适量氯仿溶解,与大孔树脂D101干法拌样,然后用大孔树脂柱粗分离,以甲醇/水溶液作为流动相,按40%、60%、80%、100%洗脱。收集80%甲醇水溶液洗脱洗脱流份,减压浓缩回收溶液,得到浸膏为总二萜部位。3. Macroporous resin D101 adsorption dry sample mixing section: the petroleum ether total extract is dissolved in an appropriate amount of chloroform, mixed with macroporous resin D101 dry method, and then roughly separated by a macroporous resin column, using methanol/water solution as the mobile phase , according to 40%, 60%, 80%, 100% elution. Collect 80% methanol aqueous solution to elute the eluted fraction, concentrate and recover the solution under reduced pressure, and obtain the extract as the total diterpene fraction.

4.硅胶分离:以适量氯仿溶解后硅胶拌样,装硅胶柱粗分离,用石油醚/乙酸乙酯作为洗脱液进行梯度洗脱,得到8个主要部位(Fr I-VIII),其中Fr VII以C18(FujiSilysia Chemical公司)柱分离,再得10个亚部位subFr1-10。目标化合物主要在subFr8-9。4. Silica gel separation: mix the sample with silica gel after dissolving an appropriate amount of chloroform, install a silica gel column for rough separation, and use petroleum ether/ethyl acetate as the eluent for gradient elution to obtain 8 main parts (Fr I-VIII), of which Fr VII was separated on a C18 (FujiSilysia Chemical Company) column to obtain 10 subparts subFr1-10. The target compounds are mainly in subFr8-9.

5.Sephadex凝胶纯化:对亚部位subFr8-9,再上Sephadex凝胶柱用甲醇洗脱,收集流份浓缩,得到目标化合物单体。5. Sephadex gel purification: for the sub-site subFr8-9, and then eluted with methanol on a Sephadex gel column, the collected fractions were concentrated to obtain the target compound monomer.

6.DIOL硅胶纯化:得到单体化合物,经DIOL硅胶再次分离纯化,得到纯度98%以上巨大戟醇甲基丁烯酸酯(Ingenol Mebutate)。6. Purification on DIOL silica gel: the monomer compound was obtained, and separated and purified again by DIOL silica gel to obtain Ingenol Mebutate with a purity of more than 98%.

上述方法的关键点在于:The key points of the above method are:

1.大孔树脂D101吸附拌样划段得到总二萜部位;1. Macroporous resin D101 absorbs and mixes samples to obtain total diterpene parts;

2.Sephadex凝胶纯化得到化合物单体;2. Sephadex gel purification to obtain the compound monomer;

3.DIOL硅胶纯化得到高纯目标原料单体。3. DIOL silica gel purification to obtain high-purity target raw material monomer.

实施例2Example 2

巨大戟醇甲基丁烯酸酯(Ingenol Mebutate)的制备:Preparation of Ingenol Mebutate:

从南欧大戟全草植物分离原料药物巨大戟醇甲基丁烯酸酯:Isolation of raw material drug ingenol methacrylate from whole plant of Euphorbia euphorbia:

南欧大戟(Euphorbia peplus Linn)采集于昆明北郊,干燥全草20kg,切碎后以甲醇浸泡,加热回流提取三次(3×100L),过滤除去残渣,滤液浓缩后得总浸膏约6kg,浸膏以20L水混悬分散后,体积比1:1石油醚萃取5次,浓缩石油醚部分,得石油醚总浸膏4kg,以适量氯仿溶解浸膏,用大孔树脂D101(天津市海光化工有限公司)干法拌样,然后用大孔树脂柱粗分离,以甲醇/水溶液作为流动相,按40%、60%、80%、100%洗脱。对80%甲醇洗脱液浓缩回收得总二萜部位300g,以适量氯仿溶解后硅胶(200~300目)拌样,装硅胶柱粗分离,以石油醚:乙酸乙酯(20:1-0:1)进行梯度洗脱,得到8个主要部位(Fr I-VIII),其中Fr VII以C18(Fuji Silysia Chemical公司)柱分离,得10个亚部位subFr1-10,subFr9再上sephadex凝胶柱用甲醇洗脱,得到目标化合物(106mg),纯度90%以上。再次经DIOL(FujiSilysia Chemical公司)分离纯化,得到巨大戟醇甲基丁烯酸酯(Ingenol Mebutate)(95mg),纯度98%以上,得率百万分之4.75%。Euphorbia peplus Linn was collected in the northern suburbs of Kunming, dried whole herb 20kg, chopped, soaked in methanol, heated and refluxed for three times (3×100L), filtered to remove the residue, and the filtrate was concentrated to obtain a total extract of about 6kg. After the extract was suspended and dispersed in 20L of water, it was extracted 5 times with petroleum ether at a volume ratio of 1:1, and the petroleum ether part was concentrated to obtain 4kg of total petroleum ether extract. Chemical Co., Ltd.) dry-mixed sample, and then roughly separated with a macroporous resin column, using methanol/water solution as the mobile phase, and eluted by 40%, 60%, 80%, and 100%. Concentrate and recover the 80% methanol eluent to obtain 300 g of total diterpene parts, dissolve with an appropriate amount of chloroform, mix the sample with silica gel (200-300 mesh), install a silica gel column for rough separation, and use petroleum ether: ethyl acetate (20:1-0 : 1) Carry out gradient elution to obtain 8 main parts (Fr I-VIII), wherein Fr VII is separated by C18 (Fuji Silysia Chemical Company) column, and 10 sub-parts subFr1-10 are obtained, and subFr9 is put on a sephadex gel column Eluted with methanol, the target compound (106 mg) was obtained with a purity of over 90%. Separation and purification by DIOL (FujiSilysia Chemical Company) again gave Ingenol Mebutate (95 mg) with a purity of over 98% and a yield of 4.75 parts per million.

Ingenol Mebutate的化学结构表征:Chemical structure characterization of Ingenol Mebutate:

Ingenol Mebutate,无定型粉末(amorphous powder),[α]25 D+46.6(0.25,MeOH)。其波谱数据为:Ingenol Mebutate, amorphous powder, [α] 25 D +46.6 (0.25, MeOH). Its spectral data are:

紫外光谱UV(MeOH)λmax(logε):203(4.03)nm;Ultraviolet spectrum UV (MeOH) λ max (log ε): 203 (4.03) nm;

红外光谱IR(KBr)υmax:3434,2928,1715,1457,1382,1231,1156,1040cm-1Infrared spectrum IR (KBr) υ max : 3434, 2928, 1715, 1457, 1382, 1231, 1156, 1040cm -1 ;

氢谱1H NMR(600MHz,CDCl3)δ:5.99(1H,m,H-1),5.57(1H,s,H-3),4.01(1H,s,H-5),6.00(1H,m,H-7),4.14(1H,m,H-8),0.88(1H,dd,J=11.7,8.5Hz,H-9),0.65(1H,dd,J=15.1,8.6Hz,H-11),2.24(1H,m,H-12),1.70(1H,m,H-12),2.52(1H,m,H-13),1.75(3H,brs,H-16),4.09(2H,m,H-17),1.01(3H,s,H-18),1.04(3H,s,H-19),0.93(3H,d,J=7.1Hz,H-20),6.11(1H,tt,J=7.3,3.6Hz,H-3’),1.97(3H,dd,J=7.2,1.2Hz,H-4’),1.88(3H,m,H-5’);Hydrogen spectrum 1 H NMR (600MHz, CDCl 3 ) δ: 5.99(1H,m,H-1),5.57(1H,s,H-3),4.01(1H,s,H-5),6.00(1H, m, H-7), 4.14 (1H, m, H-8), 0.88 (1H, dd, J=11.7, 8.5Hz, H-9), 0.65 (1H, dd, J=15.1, 8.6Hz, H -11),2.24(1H,m,H-12),1.70(1H,m,H-12),2.52(1H,m,H-13),1.75(3H,brs,H-16),4.09( 2H,m,H-17),1.01(3H,s,H-18),1.04(3H,s,H-19),0.93(3H,d,J=7.1Hz,H-20),6.11(1H ,tt,J=7.3,3.6Hz,H-3'),1.97(3H,dd,J=7.2,1.2Hz,H-4'),1.88(3H,m,H-5');

碳谱13C NMR(150MHz,CDCl3)δ:131.9(C-1),135.9(C-2),82.4(C-3),84.9(C-4),76.1(C-5),139.5(C-6),128.1(C-7),43.4(C-8),22.8(C-9),24.0(C-10),23.2(C-11),30.9(C-12),38.3(C-13),207.4(C-14),71.9(C-15),15.5(C-16),66.9(C-16),28.4(C-18),15.5(C-19),17.1(C-20),168.6(C-1’),127.3(C-2’),139.4(C-3’),15.9(C-4’),20.8(C-5’)。Carbon Spectrum 13 C NMR (150MHz, CDCl 3 ) δ: 131.9(C-1), 135.9(C-2), 82.4(C-3), 84.9(C-4), 76.1(C-5), 139.5( C-6), 128.1(C-7), 43.4(C-8), 22.8(C-9), 24.0(C-10), 23.2(C-11), 30.9(C-12), 38.3(C -13), 207.4(C-14), 71.9(C-15), 15.5(C-16), 66.9(C-16), 28.4(C-18), 15.5(C-19), 17.1(C- 20), 168.6 (C-1'), 127.3 (C-2'), 139.4 (C-3'), 15.9 (C-4'), 20.8 (C-5').

与现有技术相比,本发明的工艺方法有如下的优益性:1)大孔树脂D101直接吸附拌样划段得到总二萜部位,与常规的溶剂溶解湿法上大孔树脂D101柱层析样品不同;2)Sephadex凝胶柱层析纯化得到化合物单体;3)DIOL硅胶柱层析纯化得到高纯目标原料单体,将DIOL硅胶柱层析高效纯化用于工业药物原料的纯化未见报道。该工艺方法具备分离纯化快捷简单,高效高纯,成本较低等优点。Compared with the prior art, the process method of the present invention has the following advantages: 1) The macroporous resin D101 directly absorbs and mixes the samples and divides to obtain the total diterpene parts, and the macroporous resin D101 column on the conventional solvent-dissolved wet method Chromatographic samples are different; 2) Sephadex gel column chromatography purification to obtain compound monomers; 3) DIOL silica gel column chromatography purification to obtain high-purity target raw material monomers, and DIOL silica gel column chromatography for efficient purification of industrial pharmaceutical raw materials None reported. The process method has the advantages of fast and simple separation and purification, high efficiency and high purity, and low cost.

Claims (1)

1. the preparation method of ingenol methyl butene acid esters, it is characterised in that the method comprises the steps:Raw material is extracted, stone Oily ether extraction, macroporous resin D101 absorption dry method are mixed sample and draw section, silica gel separation, Sephadex gel-purifieds, DIOL silica gel purifications,
Described raw material is extracted as:Southern Europe Radix Euphorbiae Pekinensis or congener herb are taken, is dried, soaked with methanol after chopping, be heated to reflux Extract three times, be filtered to remove residue, after filtrate concentration, obtain total extractum;
Described petroleum ether extraction is:Total extractum water is suspended after dispersion, with volume ratio 1:1 petroleum ether extraction 5 times, point liquid concentration stone Oily ether moiety, obtains the total extractum of petroleum ether;
It is, with the total extractum of petroleum ether, to be dissolved with chloroform, with macroporous resin that described macroporous resin D101 absorption dry method is mixed sample and draws section D101 dry method mixes sample, then uses macroporous resin column crude separation, using methanol/water solution as mobile phase, by 40%, 60%, 80%, 100% eluting, collects 80% methanol aqueous solution eluting stream part, and concentrating under reduced pressure reclaims solution, obtains extractum total diterpene position;
The silica gel is separated into:With silica gel mixed sample after chloroform dissolving, silicagel column crude separation is filled, petrol ether/ethyl acetate conduct is used Eluent carries out gradient elution, obtains 8 main portions Fr I-VIII, wherein Fr VII with C18 post separations, then 10 it is sub- Position subFr1-10;
The Sephadex gel-purifieds are:To sub-portion position subFr8-9, then upper Sephadex gel column methanol-eluted fractions, collect Stream part is concentrated, and obtains target compound monomer;
The DIOL silica gel purifications are:The monomeric compound that previous step is obtained, Jing DIOL silica gel are isolated and purified again, obtain pure The ingenol methyl butene acid esters of degree more than 98%;
Described method is dried to take southern Europe Radix Euphorbiae Pekinensis herb, is soaked with methanol, heating and refluxing extraction three times after chopping, is crossed and is filtered Residue is removed, total extractum after filtrate concentration, is obtained, extractum is suspended with 20L water after dispersion, volume ratio 1:1 petroleum ether extraction 5 times, concentrates stone Oily ether moiety, obtains the total extractum of petroleum ether, dissolves extractum with appropriate chloroform, mixes sample with macroporous resin D101 dry method, then use macropore Resin column crude separation, using methanol/water solution as mobile phase, by 40%, 60%, 80%, 100% eluting;80% methanol is washed De- liquid concentration and recovery obtains total diterpene position, mixes sample with 200~300 mesh of silica gel after the dissolving of appropriate chloroform, fills silicagel column crude separation, with 20:1‐0:1 petroleum ether:Ethyl acetate carries out gradient elution, obtains 8 main portions Fr I-VIII, wherein Fr VII with C18 post separations, obtain 10 sub-portion position subFr1-10, and subFr9 goes up sephadex gel column methanol-eluted fractions again, obtains purity More than 90% target compound, then Jing DIOL isolate and purify, and obtain the ingenol methyl butene acid esters of purity more than 98% Ingenol Mebutate。
CN201510066743.3A 2015-02-09 2015-02-09 A kind of preparation method of the material medicine ingenol methyl butene acid esters for treating actinic keratosiss Active CN104649901B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510066743.3A CN104649901B (en) 2015-02-09 2015-02-09 A kind of preparation method of the material medicine ingenol methyl butene acid esters for treating actinic keratosiss

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510066743.3A CN104649901B (en) 2015-02-09 2015-02-09 A kind of preparation method of the material medicine ingenol methyl butene acid esters for treating actinic keratosiss

Publications (2)

Publication Number Publication Date
CN104649901A CN104649901A (en) 2015-05-27
CN104649901B true CN104649901B (en) 2017-03-29

Family

ID=53241608

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510066743.3A Active CN104649901B (en) 2015-02-09 2015-02-09 A kind of preparation method of the material medicine ingenol methyl butene acid esters for treating actinic keratosiss

Country Status (1)

Country Link
CN (1) CN104649901B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105152889A (en) * 2015-08-19 2015-12-16 西安岳达植物科技有限公司 Extraction method of ingenol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
SI2595948T1 (en) * 2010-07-20 2019-12-31 Leo Laboratories Limited A method of producing ingenol-3-angelate

Also Published As

Publication number Publication date
CN104649901A (en) 2015-05-27

Similar Documents

Publication Publication Date Title
CN104327127B (en) Method for preparing angroside C, aucubin and harpagide through separation and purification by high-speed countercurrent chromatography
EP2650301B1 (en) Method for preparing albiflorin and paeoniflorin
CN107304213B (en) Method and equipment for processing poppy extract
CN101863935B (en) Preparation method of 1,4-di-[4-(glucosyloxy) benzyl]-2-isobutyl malate comparison product
CN102372754A (en) Method for preparing specnuezhenide
CN102924537B (en) Method for preparing hyperoside and isoquercitrin simultaneously from dogbane leaves
CN100422191C (en) The method for separating and preparing triptolide diol from tripterygium wilfordii
CN101941961B (en) Method for extracting and separating kaempferol from impatiens balsamina
CN104649901B (en) A kind of preparation method of the material medicine ingenol methyl butene acid esters for treating actinic keratosiss
CN106496292A (en) A kind of method for preparing 6 iridoid glycoside constituents from Fructus Gardeniae simultaneously
CN106008445A (en) Flavone and lignin compound and extracting method thereof
CN105061212B (en) A kind of preparation method of neochlorogenic acid
CN109553618A (en) A kind of extracting method of matrine
CN102391328B (en) Method for simultaneously preparing chemical reference substances magnoloside A and magnoloside B
CN104370814B (en) A method for extracting sea papaverine from bundled fairy rope
CN102093454B (en) Preparation method of alisol C monoacetic ester
CN101085794B (en) Method for preparing 10-deacetyl asperulosidic acid methyl ester
CN105016982A (en) Method for extracting, separating and purifying honokiol and magnolol from magnolia officinalis
CN111233629A (en) Method for preparing compound BZ-92 from traditional Chinese medicine bighead atractylodes rhizome
CN114349808B (en) Separation and purification method of rabdosia amethystoides saponin A and B monomers and application thereof
CN1318438C (en) Method for preparing tanning material bonducin
CN103601788A (en) Method of extracting and separating triterpenoid ellagitannin compound from castanopsis fissa leaves
CN101863882B (en) A kind of method of separating and purifying piperonoid B
CN106188178A (en) A kind of method preparing protodioscin
CN111704640B (en) Method for preparing citrusin from Uncaria chinensis by high-speed countercurrent chromatography

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
OL01 Intention to license declared
OL01 Intention to license declared